Question 1 The financial controller has supplied you with the following information (#) in s financial statements for the year ended 30 June 2019 5 Lad correctly oplied the provision of IAS . Totable Assets (b) Sadypent the following amounts on research and development in the year ended 30 June 2000 General research expenditure 31,200 ProjectX Development expenditure 101,100 Pre-fachlesting costs forway 2020) 6.150 Staltraining (April 2009 15.100 175.950 The following dates are relevant to Project and its product, the Grande 1 October 2015 Pret med 1 May 2019 Project considered to have led to a technically feasible and commercially viable product, the Grande 30 June 2019 Developerspenditure Botad 200 21 March 2000 Development and receased 1 April 2020 The Grande Launched The Grande is selling well. It is expected that the Grande will have a useful life of three years from the launch date fore it is superseded Sad also purchased a machine for use in Project X and then in subsequent production of the Grande. The machine cost 60.000 on 1 July 2019 and has a five-year useful life All development expenditure accrued evenly over the relevant year, except where indicated. Lad wishes to capitalise the maximuttunt possible ey On March 2020 S Lad paid 40.000 for a patient. This allows Stad role we of new technology for five years, which will allow it to expand its matufacturing capacity Requirement Prepare the note to the financial statements for the year ended 30 June 2020 showing the movements ca intangible assets. A total column is not required. (% marks) Parlos Questi Gabby, the finance director of Tara La prepared the draft financial statements for the year andet 30 September 2020. before being taken ill. The managing director hasiven Gabby's file to Eldora, the financial controller, to enable berta complete the financial statements. Both Gabby and Elders Question 1 The financial controller has supplied you with the following information (#) in s financial statements for the year ended 30 June 2019 5 Lad correctly oplied the provision of IAS . Totable Assets (b) Sadypent the following amounts on research and development in the year ended 30 June 2000 General research expenditure 31,200 ProjectX Development expenditure 101,100 Pre-fachlesting costs forway 2020) 6.150 Staltraining (April 2009 15.100 175.950 The following dates are relevant to Project and its product, the Grande 1 October 2015 Pret med 1 May 2019 Project considered to have led to a technically feasible and commercially viable product, the Grande 30 June 2019 Developerspenditure Botad 200 21 March 2000 Development and receased 1 April 2020 The Grande Launched The Grande is selling well. It is expected that the Grande will have a useful life of three years from the launch date fore it is superseded Sad also purchased a machine for use in Project X and then in subsequent production of the Grande. The machine cost 60.000 on 1 July 2019 and has a five-year useful life All development expenditure accrued evenly over the relevant year, except where indicated. Lad wishes to capitalise the maximuttunt possible ey On March 2020 S Lad paid 40.000 for a patient. This allows Stad role we of new technology for five years, which will allow it to expand its matufacturing capacity Requirement Prepare the note to the financial statements for the year ended 30 June 2020 showing the movements ca intangible assets. A total column is not required. (% marks) Parlos Questi Gabby, the finance director of Tara La prepared the draft financial statements for the year andet 30 September 2020. before being taken ill. The managing director hasiven Gabby's file to Eldora, the financial controller, to enable berta complete the financial statements. Both Gabby and Elders
